Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2018 3
2019 2
2020 1
2021 1
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean vezina a[au] (47 results)?
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR, Anuskina AA, Gorgul YA, Shestakova AD, Maidin MA, Belyaev AM, Baboshkina LS, Iyevleva AG, Imyanitov EN. Martianov AS, et al. Among authors: venina ar. Int J Mol Sci. 2023 Mar 2;24(5):4868. doi: 10.3390/ijms24054868. Int J Mol Sci. 2023. PMID: 36902296 Free PMC article.
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
Tiurin VI, Preobrazhenskaya EV, Mitiushkina NV, Romanko AA, Anuskina AA, Mulkidjan RS, Saitova ES, Krivosheyeva EA, Kharitonova ED, Shevyakov MP, Tryakin IA, Aleksakhina SN, Venina AR, Sokolova TN, Martianov AS, Shestakova AD, Ivantsov AO, Iyevleva AG, Imyanitov EN. Tiurin VI, et al. Among authors: venina ar. Int J Mol Sci. 2023 Jun 23;24(13):10530. doi: 10.3390/ijms241310530. Int J Mol Sci. 2023. PMID: 37445709 Free PMC article.
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Daks A, Mamontova V, Fedorova O, Petukhov A, Shuvalov O, Parfenyev S, Netsvetay S, Venina A, Kizenko A, Imyanitov E, Barlev N. Daks A, et al. Among authors: venina a. Biochem Biophys Res Commun. 2021 Oct 1;572:41-48. doi: 10.1016/j.bbrc.2021.07.086. Epub 2021 Jul 31. Biochem Biophys Res Commun. 2021. PMID: 34343833
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
Sokolenko AP, Sultanova LV, Stepanov IA, Romanko AA, Venina AR, Sokolova TN, Musayeva HS, Tovgereeva MY, Magomedova MK, Akhmatkhanov KU, Vagapova EI, Suleymanov EA, Vasilyeva EV, Bakaeva EK, Bizin IV, Aleksakhina SN, Imyanitov EN. Sokolenko AP, et al. Among authors: venina ar. Cancer Med. 2023 Feb;12(3):3167-3171. doi: 10.1002/cam4.5159. Epub 2022 Aug 23. Cancer Med. 2023. PMID: 36000185 Free PMC article.
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN. Kuligina ES, et al. Among authors: venina ar. Breast Cancer Res Treat. 2020 Feb;179(3):731-742. doi: 10.1007/s10549-019-05492-6. Epub 2019 Nov 21. Breast Cancer Res Treat. 2020. PMID: 31754952
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
Iyevleva AG, Aleksakhina SN, Sokolenko AP, Baskina SV, Venina AR, Anisimova EI, Bizin IV, Ivantsov AO, Belysheva YV, Chernyakova AP, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: venina ar. Breast Cancer Res Treat. 2022 Apr;192(2):283-291. doi: 10.1007/s10549-022-06517-3. Epub 2022 Jan 12. Breast Cancer Res Treat. 2022. PMID: 35020107
BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
Frank GA, Aleksakhina SN, Zavalishina LE, Kekeyeva TV, Venina AR, Ivantsov AO, Mitiushkina NV, Moiseyenko AV, Pfeifer W, Strelkova TN, Imyanitov EN. Frank GA, et al. Among authors: venina ar. Melanoma Res. 2016 Oct;26(5):442-7. doi: 10.1097/CMR.0000000000000278. Melanoma Res. 2016. PMID: 27433783 No abstract available.
Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
Yanus GA, Akhapkina TA, Ivantsov AO, Preobrazhenskaya EV, Aleksakhina SN, Bizin IV, Sokolenko AP, Mitiushkina NV, Kuligina ES, Suspitsin EN, Venina AR, Holmatov MM, Zaitseva OA, Yatsuk OS, Pashkov DV, Belyaev AM, Togo AV, Imyanitov EN, Iyevleva AG. Yanus GA, et al. Among authors: venina ar. Clin Genet. 2018 May;93(5):1015-1021. doi: 10.1111/cge.13228. Epub 2018 Mar 9. Clin Genet. 2018. PMID: 29406563
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
Moiseyenko FV, Moiseyenko VM, Aleksakhina SN, Chubenko VA, Volkov NM, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Ivantsov AO, Venina AR, Preobrazhenskaya EV, Mitiushkina NV, Iyevleva AG, Imyanitov EN. Moiseyenko FV, et al. Among authors: venina ar. Oncol Res Treat. 2016;39(10):605-614. doi: 10.1159/000449024. Epub 2016 Sep 15. Oncol Res Treat. 2016. PMID: 27710972 Clinical Trial.
14 results